Literature DB >> 19668114

No association of the Val66Met polymorphism of the brain-derived neurotrophic factor with hippocampal volume in major depression.

Frank Jessen1, Anna Schuhmacher, Ole von Widdern, Vera Guttenthaler, Susanne Hofels, Husam Suliman, Lukas Scheef, Wolfgang Block, Horst Urbach, Wolfgang Maier, Astrid Zobel.   

Abstract

Recently, an association of the Val66Met polymorphism of the brain-derived neurotrophic factor with hippocampal volume in patients with major depression has been reported. Here, we aimed at replicating this finding in an independent German sample. We included 79 patients with unipolar major depressive episodes and 84 healthy comparison participants. The brain-derived neurotrophic factor Val66Met polymorphism was determined in all participants. The volume of the hippocampus was manually traced on high-resolution magnetic resonance images. The hippocampal volumes of patients were significantly smaller than those of the comparison participants, confirming previous reports. There was, however, no Val66Met effect on hippocampal volume in either group. To conclude, we did not replicate the Val66Met effect on hippocampal volume in neither patients with major depression nor in healthy participants.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19668114     DOI: 10.1097/YPG.0b013e32832080ce

Source DB:  PubMed          Journal:  Psychiatr Genet        ISSN: 0955-8829            Impact factor:   2.458


  17 in total

1.  Reduced hippocampal volumes in healthy carriers of brain-derived neurotrophic factor Val66Met polymorphism: meta-analysis.

Authors:  Tomas Hajek; Miloslav Kopecek; Cyril Höschl
Journal:  World J Biol Psychiatry       Date:  2011-07-04       Impact factor: 4.132

2.  Dosage effects of BDNF Val66Met polymorphism on cortical surface area and functional connectivity.

Authors:  Chao Wang; Yuanchao Zhang; Bing Liu; Haixia Long; Chunshui Yu; Tianzi Jiang
Journal:  J Neurosci       Date:  2014-02-12       Impact factor: 6.167

Review 3.  Neuroimaging genomic studies in major depressive disorder: A systematic review.

Authors:  Hui-Feng Zhang; David Mellor; Dai-Hui Peng
Journal:  CNS Neurosci Ther       Date:  2018-02-23       Impact factor: 5.243

4.  Widespread white matter but focal gray matter alterations in depressed individuals with thoughts of death.

Authors:  Warren D Taylor; Brian Boyd; Douglas R McQuoid; Kamil Kudra; Ayman Saleh; James R MacFall
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2015-05-08       Impact factor: 5.067

5.  The brain-derived neurotrophic factor Val66Met polymorphism, hippocampal volume, and cognitive function in geriatric depression.

Authors:  Sophiya Benjamin; Douglas R McQuoid; Guy G Potter; Martha E Payne; James R MacFall; David C Steffens; Warren D Taylor
Journal:  Am J Geriatr Psychiatry       Date:  2010-04       Impact factor: 4.105

Review 6.  Depression and risk of developing dementia.

Authors:  Amy L Byers; Kristine Yaffe
Journal:  Nat Rev Neurol       Date:  2011-05-03       Impact factor: 42.937

7.  Hippocampal volumes and the brain-derived neurotrophic factor val66met polymorphism in geriatric major depression.

Authors:  Dora Kanellopoulos; Faith M Gunning; Sarah S Morimoto; Matthew J Hoptman; Christopher F Murphy; Robert E Kelly; Charles Glatt; Kelvin O Lim; George S Alexopoulos
Journal:  Am J Geriatr Psychiatry       Date:  2011-01       Impact factor: 4.105

8.  No effect of 5HTTLPR or BDNF Val66Met polymorphism on hippocampal morphology in major depression.

Authors:  J Cole; D R Weinberger; V S Mattay; X Cheng; A W Toga; P M Thompson; G Powell-Smith; S Cohen-Woods; A Simmons; P McGuffin; C H Y Fu
Journal:  Genes Brain Behav       Date:  2011-07-12       Impact factor: 3.449

9.  Involvement of BDNF in age-dependent alterations in the hippocampus.

Authors:  Oliver von Bohlen und Halbach
Journal:  Front Aging Neurosci       Date:  2010-08-13       Impact factor: 5.750

10.  The Role of Neurotrophins in Major Depressive Disorder.

Authors:  Cheng Jiang; Stephen R Salton
Journal:  Transl Neurosci       Date:  2013-03-01       Impact factor: 1.757

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.